Earnings Call · Q2 FY2021·2021-08-10

Q2 21EPS +8.00%·Rev n/aQ1 21EPS -74.80%·Rev n/aQ4 20EPS -42.05%·Rev n/aQ3 20EPS -87.76%·Rev n/a⚠ consensus missing

Arcturus Therapeutics Holdings Inc. ARCT

Neda Safarzadeh — Investor Relations

Joseph Payne — President and CEO

Steve Hughes — Chief Medical Officer

Andy Sassine — CFO

+4.9%1d on move date+4.7% vs SPY3d+3.5%5d−3.0%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ARCT calls or request research access.

More ARCT calls Browse calls Request research access